237 related articles for article (PubMed ID: 34084150)
1. Radiofrequency Ablation for Cervical Metastatic Lymph Nodes in Children and Adolescents With Papillary Thyroid Carcinoma: A Preliminary Study.
Yan L; Zhang Y; Jiang B; Luo Y
Front Endocrinol (Lausanne); 2021; 12():624054. PubMed ID: 34084150
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound-guided Radiofrequency Ablation for Cervical Lymph Nodes Metastasis from Papillary Thyroid Carcinoma.
Guang Y; Luo YK; Zhang Y; Zhang MB; Li N; Zhang Y; Tang J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Feb; 40(1):67-71. PubMed ID: 29532783
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma.
Guang Y; Luo Y; Zhang Y; Zhang M; Li N; Zhang Y; Tang J
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1555-1562. PubMed ID: 28342000
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of microwave ablation for cervical metastatic lymph nodes arising post resection of papillary thyroid carcinoma: a retrospective study.
Cao XJ; Wei Y; Zhao ZL; Peng LL; Li Y; Yu MA
Int J Hyperthermia; 2020; 37(1):450-455. PubMed ID: 32369712
[No Abstract] [Full Text] [Related]
5. Ultrasonography-guided percutaneous radiofrequency ablation for cervical lymph node metastasis from thyroid carcinoma.
Wang L; Ge M; Xu D; Chen L; Qian C; Shi K; Liu J; Chen Y
J Cancer Res Ther; 2014 Nov; 10 Suppl():C144-9. PubMed ID: 25450273
[TBL] [Abstract][Full Text] [Related]
6. Longer-term outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer.
Chung SR; Baek JH; Choi YJ; Lee JH
Eur Radiol; 2019 Sep; 29(9):4897-4903. PubMed ID: 30805701
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of thermal ablation for cervical metastatic lymph nodes in papillary thyroid carcinoma: A systematic review and meta-analysis.
Tang W; Tang X; Jiang D; Zhang X; Wang R; Niu X; Zang Y; Zhang M; Wang X; Zhao C
Front Endocrinol (Lausanne); 2022; 13():967044. PubMed ID: 36072932
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for level V metastasis in patients with N1b papillary thyroid cancer.
Kang JG; Choi JE; Kang SH
World J Surg Oncol; 2022 Sep; 20(1):327. PubMed ID: 36180912
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation for treatment of locally recurrent thyroid cancer presenting as a metastatic lymph node with dense macrocalcification: A case report and literature review.
Yoo RE; Kim JH; Paeng JC; Park YJ
Medicine (Baltimore); 2018 Mar; 97(9):e0003. PubMed ID: 29489641
[TBL] [Abstract][Full Text] [Related]
10. Active Surveillance of Small Metastatic Lymph Nodes as an Alternative to Surgery in Selected Patients with Low-Risk Papillary Thyroid Cancer: A Retrospective Cohort Study.
Jerkovich F; Abelleira E; Bueno F; Guerrero L; Pitoia F
Thyroid; 2022 Oct; 32(10):1178-1183. PubMed ID: 35876426
[No Abstract] [Full Text] [Related]
11. Ultrasonography-Guided Thermal Ablation for Cervical Lymph Node Metastasis of Recurrent Papillary Thyroid Carcinoma: Is it Superior to Surgical Resection?
Zhang X; Ni T; Zhang W
Front Endocrinol (Lausanne); 2022; 13():907195. PubMed ID: 35832431
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of radiofrequency ablation for locally recurrent papillary thyroid carcinoma.
Yang Z; Yan L; Xiao J; Li W; Li X; Li Y; Zhang M; Luo Y
Int J Hyperthermia; 2023; 40(1):2191912. PubMed ID: 37164353
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-Guided Radiofrequency Ablation
He H; Wu R; Zhao J; Song Q; Zhang Y; Luo Y
Front Endocrinol (Lausanne); 2021; 12():734432. PubMed ID: 34512557
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Follow-Up Results of Ultrasound-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: More Than 5-Year Follow-Up for 84 Tumors.
Cho SJ; Baek SM; Lim HK; Lee KD; Son JM; Baek JH
Thyroid; 2020 Dec; 30(12):1745-1751. PubMed ID: 32375570
[No Abstract] [Full Text] [Related]
15. Cervical Lymph Node Fine-Needle Aspiration and Needle-Wash Thyroglobulin Reflex Test for Papillary Thyroid Carcinoma.
Zhang X; Howell JM; Huang Y
Endocr Pathol; 2018 Dec; 29(4):346-350. PubMed ID: 30203321
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of radiofrequency ablation for unifocal low-risk papillary thyroid microcarcinoma: a large cohort study of 414 patients.
Yan L; Lan Y; Xiao J; Lin L; Jiang B; Luo Y
Eur Radiol; 2021 Feb; 31(2):685-694. PubMed ID: 32813103
[TBL] [Abstract][Full Text] [Related]
17. Rigorous radiofrequency ablation can completely treat low-risk small papillary thyroid carcinoma without affecting subsequent surgical management.
Li X; Li J; Qiao Z; Yan L; Xiao J; Li Y; Zhang M; Luo Y
Eur Radiol; 2023 Jun; 33(6):4189-4197. PubMed ID: 36538070
[TBL] [Abstract][Full Text] [Related]
18. Serum antithyroglobulin antibodies interfere with thyroglobulin detection in fine-needle aspirates of metastatic neck nodes in papillary thyroid carcinoma.
Jeon MJ; Park JW; Han JM; Yim JH; Song DE; Gong G; Kim TY; Baek JH; Lee JH; Shong YK; Kim WB
J Clin Endocrinol Metab; 2013 Jan; 98(1):153-60. PubMed ID: 23144473
[TBL] [Abstract][Full Text] [Related]
19. Comparison of ultrasound-guided radiofrequency ablation versus thyroid lobectomy for T1bN0M0 papillary thyroid carcinoma.
Yan L; Li X; Li Y; Xiao J; Zhang M; Luo Y
Eur Radiol; 2023 Jan; 33(1):730-740. PubMed ID: 35895122
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: A retrospective study with more than 5 years of follow-up.
Yan L; Li Y; Li XY; Xiao J; Tang J; Luo Y
Cancer; 2023 Aug; 129(16):2469-2478. PubMed ID: 37060239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
